![logo](/logos/NTH.MC.webp)
Naturhouse Health, S.A.
MSE:NTH.MC
1.77 (EUR) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 50.407 | 52.403 | 57.594 | 55.081 | 81.667 | 87.289 | 94.7 | 97.815 | 95.792 | 95.731 | 59.881 |
Cost of Revenue
| 25.298 | 14.92 | 16.335 | 15.876 | 23.841 | 25.158 | 27.12 | 28.638 | 27.832 | 28.708 | 20.042 |
Gross Profit
| 25.109 | 37.483 | 41.259 | 39.205 | 57.826 | 62.131 | 67.58 | 69.177 | 67.96 | 67.023 | 39.839 |
Gross Profit Ratio
| 0.498 | 0.715 | 0.716 | 0.712 | 0.708 | 0.712 | 0.714 | 0.707 | 0.709 | 0.7 | 0.665 |
Reseach & Development Expenses
| 0.004 | 0.008 | 0.008 | 0.032 | 0.012 | 0.027 | 0.02 | 0.026 | 0.028 | 0 | 0 |
General & Administrative Expenses
| 6.619 | 4.874 | 3.463 | 4.053 | 5.06 | 5.325 | 4.679 | 4.977 | 4.271 | 4.216 | 5.892 |
Selling & Marketing Expenses
| 2.671 | 5.287 | 5.673 | 4.551 | 8.368 | 8.196 | 8.24 | 7.939 | 8.393 | 8.264 | 3.883 |
SG&A
| 9.29 | 10.161 | 9.136 | 8.604 | 13.428 | 13.521 | 12.919 | 12.916 | 12.664 | 12.48 | 9.775 |
Other Expenses
| 0.473 | 14.478 | 14.579 | 16.23 | 25.708 | -0.021 | 26.466 | 24.638 | 22.641 | 22.057 | 17.431 |
Operating Expenses
| 8.821 | 24.639 | 23.715 | 24.834 | 39.136 | 40.075 | 39.385 | 37.554 | 35.305 | 34.537 | 27.206 |
Operating Income
| 16.288 | 12.853 | 17.338 | 13.225 | 19.179 | 22.148 | 28.262 | 31.375 | 32.474 | 32.461 | 12.836 |
Operating Income Ratio
| 0.323 | 0.245 | 0.301 | 0.24 | 0.235 | 0.254 | 0.298 | 0.321 | 0.339 | 0.339 | 0.214 |
Total Other Income Expenses Net
| -0.723 | 0.25 | 0.907 | 0.289 | 0.058 | 0.571 | 0.394 | 0.729 | 0.665 | 0.482 | 0.176 |
Income Before Tax
| 15.565 | 13.103 | 18.245 | 13.514 | 19.237 | 22.719 | 28.656 | 32.104 | 33.139 | 32.943 | 13.012 |
Income Before Tax Ratio
| 0.309 | 0.25 | 0.317 | 0.245 | 0.236 | 0.26 | 0.303 | 0.328 | 0.346 | 0.344 | 0.217 |
Income Tax Expense
| 4.168 | 3.484 | 4.879 | 4.127 | 6.031 | 7.364 | 8.808 | 9.622 | 10.376 | 10.449 | 4.56 |
Net Income
| 11.293 | 9.627 | 13.361 | 9.379 | 13.257 | 15.373 | 19.855 | 22.504 | 22.86 | 22.56 | 8.544 |
Net Income Ratio
| 0.224 | 0.184 | 0.232 | 0.17 | 0.162 | 0.176 | 0.21 | 0.23 | 0.239 | 0.236 | 0.143 |
EPS
| 0.19 | 0.16 | 0.22 | 0.16 | 0.22 | 0.26 | 0.33 | 0.38 | 0.38 | 0.38 | 0.14 |
EPS Diluted
| 0.19 | 0.16 | 0.22 | 0.16 | 0.22 | 0.26 | 0.33 | 0.38 | 0.38 | 0.38 | 0.14 |
EBITDA
| 18.551 | 15.598 | 21.008 | 18.103 | 23.297 | 23.805 | 29.779 | 33.463 | 34.737 | 34.946 | 15.364 |
EBITDA Ratio
| 0.368 | 0.298 | 0.365 | 0.329 | 0.285 | 0.273 | 0.314 | 0.342 | 0.363 | 0.365 | 0.257 |